PubMed:33115909 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":44,"end":52},"obj":"Disease"},{"id":"T2","span":{"begin":70,"end":117},"obj":"Disease"},{"id":"T3","span":{"begin":119,"end":127},"obj":"Disease"},{"id":"T4","span":{"begin":502,"end":510},"obj":"Disease"},{"id":"T5","span":{"begin":735,"end":743},"obj":"Disease"},{"id":"T6","span":{"begin":878,"end":886},"obj":"Disease"},{"id":"T7","span":{"begin":999,"end":1007},"obj":"Disease"},{"id":"T8","span":{"begin":1244,"end":1252},"obj":"Disease"},{"id":"T9","span":{"begin":1414,"end":1422},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Will vaccination refusal prolong the war on SARS-CoV-2?\nINTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that appeared in Wuhan, China in January 2020 and caused a global pandemic drastically changing everyday life. Currently, there are vaccine candidates in clinical trials and development, so it is only a matter of time before one is authorised for human use.\nMATERIALS AND METHODS: We collected public opinion survey results about attitudes towards SARS-CoV-2 vaccination conducted in 2020 in 26 European countries.\nRESULTS: The pooled surveys were conducted on a total of 24 970 participants; on average only 58% (n=14 365/24 970) of responders across Europe were willing to get a SARS-CoV-2 vaccine once it becomes available, 16% (n=3998/24 970) were neutral, and 26% (n=6607/24 970) were not planning to vaccinate against SARS-CoV-2. Such a low vaccination response could make it exceedingly difficult to reach the herd immunity threshold for SARS-CoV-2 through vaccination.\nCONCLUSION: It is very important to start conducting educational public health activities on the topic of vaccination as soon as possible, before a vaccine becomes available, in order to improve attitudes towards SARS-CoV-2 vaccination. Only by educating the general public about the benefits, safety and efficacy of vaccines can we hope to avoid the unnecessary prolongation of the COVID-19 pandemic."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":134,"end":135},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T2","span":{"begin":211,"end":212},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T3","span":{"begin":355,"end":356},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T4","span":{"begin":401,"end":406},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T5","span":{"begin":615,"end":616},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T6","span":{"begin":733,"end":734},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T7","span":{"begin":895,"end":896},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T8","span":{"begin":1110,"end":1120},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T9","span":{"begin":1177,"end":1178},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Will vaccination refusal prolong the war on SARS-CoV-2?\nINTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that appeared in Wuhan, China in January 2020 and caused a global pandemic drastically changing everyday life. Currently, there are vaccine candidates in clinical trials and development, so it is only a matter of time before one is authorised for human use.\nMATERIALS AND METHODS: We collected public opinion survey results about attitudes towards SARS-CoV-2 vaccination conducted in 2020 in 26 European countries.\nRESULTS: The pooled surveys were conducted on a total of 24 970 participants; on average only 58% (n=14 365/24 970) of responders across Europe were willing to get a SARS-CoV-2 vaccine once it becomes available, 16% (n=3998/24 970) were neutral, and 26% (n=6607/24 970) were not planning to vaccinate against SARS-CoV-2. Such a low vaccination response could make it exceedingly difficult to reach the herd immunity threshold for SARS-CoV-2 through vaccination.\nCONCLUSION: It is very important to start conducting educational public health activities on the topic of vaccination as soon as possible, before a vaccine becomes available, in order to improve attitudes towards SARS-CoV-2 vaccination. Only by educating the general public about the benefits, safety and efficacy of vaccines can we hope to avoid the unnecessary prolongation of the COVID-19 pandemic."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1","span":{"begin":44,"end":54},"obj":"Species"},{"id":"13","span":{"begin":70,"end":117},"obj":"Species"},{"id":"14","span":{"begin":119,"end":129},"obj":"Species"},{"id":"15","span":{"begin":136,"end":153},"obj":"Species"},{"id":"16","span":{"begin":401,"end":406},"obj":"Species"},{"id":"17","span":{"begin":502,"end":512},"obj":"Species"},{"id":"18","span":{"begin":633,"end":645},"obj":"Species"},{"id":"19","span":{"begin":735,"end":745},"obj":"Species"},{"id":"20","span":{"begin":878,"end":888},"obj":"Species"},{"id":"21","span":{"begin":999,"end":1009},"obj":"Species"},{"id":"22","span":{"begin":1244,"end":1254},"obj":"Species"},{"id":"23","span":{"begin":1414,"end":1422},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"tao:has_database_id","subj":"1","obj":"Tax:2697049"},{"id":"A13","pred":"tao:has_database_id","subj":"13","obj":"Tax:2697049"},{"id":"A14","pred":"tao:has_database_id","subj":"14","obj":"Tax:2697049"},{"id":"A15","pred":"tao:has_database_id","subj":"15","obj":"Tax:2697049"},{"id":"A16","pred":"tao:has_database_id","subj":"16","obj":"Tax:9606"},{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"Tax:2697049"},{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"Tax:9606"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Tax:2697049"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Tax:2697049"},{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"Tax:2697049"},{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"Tax:2697049"},{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Will vaccination refusal prolong the war on SARS-CoV-2?\nINTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that appeared in Wuhan, China in January 2020 and caused a global pandemic drastically changing everyday life. Currently, there are vaccine candidates in clinical trials and development, so it is only a matter of time before one is authorised for human use.\nMATERIALS AND METHODS: We collected public opinion survey results about attitudes towards SARS-CoV-2 vaccination conducted in 2020 in 26 European countries.\nRESULTS: The pooled surveys were conducted on a total of 24 970 participants; on average only 58% (n=14 365/24 970) of responders across Europe were willing to get a SARS-CoV-2 vaccine once it becomes available, 16% (n=3998/24 970) were neutral, and 26% (n=6607/24 970) were not planning to vaccinate against SARS-CoV-2. Such a low vaccination response could make it exceedingly difficult to reach the herd immunity threshold for SARS-CoV-2 through vaccination.\nCONCLUSION: It is very important to start conducting educational public health activities on the topic of vaccination as soon as possible, before a vaccine becomes available, in order to improve attitudes towards SARS-CoV-2 vaccination. Only by educating the general public about the benefits, safety and efficacy of vaccines can we hope to avoid the unnecessary prolongation of the COVID-19 pandemic."}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":55},"obj":"Sentence"},{"id":"T2","span":{"begin":56,"end":69},"obj":"Sentence"},{"id":"T3","span":{"begin":70,"end":264},"obj":"Sentence"},{"id":"T4","span":{"begin":265,"end":411},"obj":"Sentence"},{"id":"T5","span":{"begin":412,"end":434},"obj":"Sentence"},{"id":"T6","span":{"begin":435,"end":568},"obj":"Sentence"},{"id":"T7","span":{"begin":569,"end":577},"obj":"Sentence"},{"id":"T8","span":{"begin":578,"end":889},"obj":"Sentence"},{"id":"T9","span":{"begin":890,"end":1030},"obj":"Sentence"},{"id":"T10","span":{"begin":1031,"end":1042},"obj":"Sentence"},{"id":"T11","span":{"begin":1043,"end":1267},"obj":"Sentence"},{"id":"T12","span":{"begin":1268,"end":1432},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Will vaccination refusal prolong the war on SARS-CoV-2?\nINTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that appeared in Wuhan, China in January 2020 and caused a global pandemic drastically changing everyday life. Currently, there are vaccine candidates in clinical trials and development, so it is only a matter of time before one is authorised for human use.\nMATERIALS AND METHODS: We collected public opinion survey results about attitudes towards SARS-CoV-2 vaccination conducted in 2020 in 26 European countries.\nRESULTS: The pooled surveys were conducted on a total of 24 970 participants; on average only 58% (n=14 365/24 970) of responders across Europe were willing to get a SARS-CoV-2 vaccine once it becomes available, 16% (n=3998/24 970) were neutral, and 26% (n=6607/24 970) were not planning to vaccinate against SARS-CoV-2. Such a low vaccination response could make it exceedingly difficult to reach the herd immunity threshold for SARS-CoV-2 through vaccination.\nCONCLUSION: It is very important to start conducting educational public health activities on the topic of vaccination as soon as possible, before a vaccine becomes available, in order to improve attitudes towards SARS-CoV-2 vaccination. Only by educating the general public about the benefits, safety and efficacy of vaccines can we hope to avoid the unnecessary prolongation of the COVID-19 pandemic."}